thestockadvisors.com

Three Favorite Stocks of Wealthy Investors

Posted on March 23rd, 2011 in aapl. Apple, Blue Chip Stocks, BMY, Bristol-myersSquibb, healthcare stocks, HealthcareStocks, India Shares, investment u, InvestmentU, marc lichtenfeld, pharmaceutical stocks, StevenHalpern, technology stocks, thestockadvisors.com, VAR, VarianMedicalSystems

Filed under: , , ,

“According to the Spectrem Group, which recently polled the country’s wealthiest people, they’re the most optimistic they’ve been in months,” says Marc Lichtenfeld.

The contributing editor to Investment U explains, “Let’s take a look at 3 stocks that millionaires (and aspiring ones) should pay attention to: Apple (AAPL), Bristol-Myers Squibb (BMY) and Varian Medical Systems (VAR).

“And according to Fidelity, 83% of millionaires surveyed said the financial crisis did not shake their confidence in investing. And of those who said they’ll invest more money in the stock market, nearly 60% of them plan to buy technology stocks. And just under half expect to acquire pharmaceutical and healthcare stocks.

Continue reading Three Favorite Stocks of Wealthy Investors

Three Favorite Stocks of Wealthy Investors originally appeared on BloggingStocks on Wed, 23 Mar 2011 15:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati


Tags: ,
Read post Add your comment

Petrobras (PBR): Brazil Firm Boasts ‘Huge Reserves’

Posted on March 18th, 2011 in brazil energy stocks, brazil stocks, BrazilStocks, cabot china emerging markets report, deepwater drilling stocks, DeepwaterDrillingStocks, energy stocks, EnergyStocks, India Shares, offshore stocks, OffshoreStocks, paul goodwin, PaulGoodwin, pbr, petrobras, steven halpern, thestockadvisors.com

The major beneficiaries of ongoing unrest in the Middle East will include companies that have lots of oil reserves, which certainly includes Brazil’s Petrobras (PBR),” notes Paul Goodwin.

The editor of Cabot China & Emerging Markets Report explains, “The company is the third largest oil and natural gas company in the world, with proven oil reserves of 14.2 billion barrels. That’s an 11% year-over-year gain in reserves, the largest increase in eight years.

“If you add in probable and possible reserves, the number rises to nearly 28.5 billion barrels. Proven natural gas reserves also took a big jump in 2010, rising more than 15% to 423 billion cubic meters.

Continue reading Petrobras (PBR): Brazil Firm Boasts ‘Huge Reserves’

Petrobras (PBR): Brazil Firm Boasts ‘Huge Reserves’ originally appeared on BloggingStocks on Fri, 18 Mar 2011 15:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati


Tags: ,
Read post Add your comment

Physical Precious Metals Basket (GLTR): All in One Metals ETF

Posted on March 18th, 2011 in all in one metals fund, ETFS Physical Precious Metals Basket, featured, gold etf, gold fund, GoldEtf, GoldFund, India Shares, investors etf report, mark salzinger, palladium, platinum, silver etf, silver fund, SilverFund, steven halpern, StevenHalpern, thestockadvisors.com

Filed under: , ,

“The ETFS Physical Precious metals Basket (GLTR) is the first physical-bullion ETF to own more than one metal. GLTR’s all-in-one convenience and relatively low expense ratio make it an attractive option,” notes exchange traded fund specialist Mark Salzinger.

The editor of The Investor’s ETF Report explains, “We like this ETF for investors who want to complement exposure to gold bullion with extensive exposure to silver and modest exposures to platinum and palladium.

Continue reading Physical Precious Metals Basket (GLTR): All in One Metals ETF

Physical Precious Metals Basket (GLTR): All in One Metals ETF originally appeared on BloggingStocks on Fri, 18 Mar 2011 10:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati


Tags:
Read post Add your comment

Sangamo (SGMO): An HIV Treatment Speculation

Posted on March 11th, 2011 in biotech stocks, biotechnology, hiv treatment stocks, India Shares, john mccamant, Sangamo Biosciences, sgmo, steven halpern, thestockadvisors.com

Filed under: ,

“Sangamo Biosciences (SGMO) has been receiving the kind of news that biotech companies dream of, with multiple main-stream news outlets picking up the story that the company is developing what may be a ‘functional cure’ for AIDS,” notes biotech sector specialist John McCamant.

The editor of The Medical Technology Stock Letter explains, “The treatments that SGMO is developing are exciting, and we see this stock going much higher this year and in subsequent years based on clinical progress.

“The company recently helped kick-off the 2011 Conference on Retroviruses and Opportunistic Infections in Boston. It offered an investigator presentation on the Phase I SB-728-902 trial of the company’s treatment for HIV infection (SB-728).

Continue reading Sangamo (SGMO): An HIV Treatment Speculation

Sangamo (SGMO): An HIV Treatment Speculation originally appeared on BloggingStocks on Fri, 11 Mar 2011 10:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati


Tags:
Read post Add your comment
« Newer posts
Older posts »